(Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with... t.co/i7e1RsNVmj
— NatCapLyme 1 hour 58 min ago.
As Drug-Resistant Superbugs Continue to Spread, U.S. Taps Pharma Giant GlaxoSmithKline to Develop New Antibiotics t.co/l493Rcvko1
— ebzauce 2 hours 23 min ago.
RT @ensighten: GlaxoSmithKline helps people do more, feel better, and live longer. We are honored to announce our new client! @GSKUS
— asmithann 2 hours 24 min ago.
Source: Daily Finance
Has a stalemate been reached in the fight against HIV? After years of significant progress, a recent development could give the impression that progress might be stalled. In late April, the largest active stud ...
Full article at: Daily Finance
More like this 4 hours ago, 5:36pm CDT
Source: Boston Business Journal
BioFlash delivers the day's life sciences headlines from New England's innovation economy. Our daily opt-in push e-mail, BioFlash, delivers the day’s life sciences headlines to the desktops of executives and ...
Full article at: Boston Business Journal
More like this 4 hours ago, 5:34pm CDT
Source: NASDAQ
Join the NASDAQ Community today and get free, instant access to portfolios, stock ratings, real-time alerts, and more! Elan Corporation 's ( ELN ) Board of Directors recently rejected Royalty Pharma's offer for the third time. Following a thorough review ...
Full article at: NASDAQ
More like this 5 hours ago, 4:24pm CDT
Source: Zacks Investment Research
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest. Today, you can see them free. Are you a new Zacks Member or a visitor to Zacks.com? One of the mo ...
Full article at: Zacks Investment Research
More like this 6 hours ago, 3:49pm CDT
Source: Daily Finance
Prescriptions of Amarin's Vascepa are on a path to the moon. The company was nice enough to include a graph plotting prescriptions since the lipid-lowering drug launched at the end of January. (You can download a larger version here.) That trend ...
Full article at: Daily Finance
More like this 6 hours ago, 3:33pm CDT
Source: The Province Daily News
TORONTO — Health Canada and drug maker GlaxoSmithKline have issued a warning that an experimental drug abandoned because it caused cancers in animal studies is being marketed to athletes as a performance-enhancing drug. Development was s ...
Full article at: The Province Daily News
More like this 6 hours ago, 3:24pm CDT
Source: Seeking Alpha
One of the biopharmaceutical companies that has been lagging the stellar performance of its peers is Exelixis (EXEL), developer of the compound cabozantinib. Cabo, which was FDA approved last year for the treatment of medullary thy ...
Full article at: Seeking Alpha
More like this 7 hours ago, 2:23pm CDT
Source: PaperCamp.com
Describe the business and explain the general pattern of change of the particular market model indicating how this change is likely to impact business operations. GlaxoSmithKline (GSK) is among the top 20 Global 500 companies and among the top five ...
Full article at: PaperCamp.com
More like this 8 hours ago, 1:44pm CDT